Topic:Medication
The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Injectable anesthetics and anesthetic adjuncts. The purpose of this article is to review the use of selected anesthetics and anesthetic adjuncts in horses. Emphasis is placed on the pharmacologic bases of their use.
Anthelmintics used in treatment of parasitic infections of horses. The common anthelmintics used to treat parasitic infections of horses are described. Dosage, anthelmintic spectrum, formulation and administration, mode of action, toxicity contraindications, and resistance of parasites to anthelmintics are included.
A clinical trial of three anaesthetic regimens for the castration of ponies. After premedication with intravenous xylazine 30 ponies were anaesthetised for castration under field conditions with intravenous ketamine, thiopentone or methohexitone. The duration of anaesthesia was adequate for surgery and the times taken to stand were similar in each group. The recovery of the ponies after ketamine was quieter than after either of the barbiturates and this may be an advantage when skilled assistance is lacking. However, all the anaesthetics appeared to be suitable for performing minor surgery in the field.
[Effectiveness of ivermectin in Strongyloides westeri cases in foals]. Efficacy of Ivermectin in combating Strongyloides westeri infection of foal. The efficacy of Ivermectin and Mebendazol in combating spontaneous Strongyloides westeri infections in foals has been tested by examining faecal egg output reduction. Ivermectin as a paste formulation was given to sucking foals and pregnant mares in a single dosage of 200 micrograms/kg bodyweight by oral administration. A high efficacy of Ivermectin in combating patent Strongyloides westeri infection could be demonstrated; no side effects have been observed. Mebendazol at a dosage rate of 8 mg/kg did not yield satisfa...
Anthelmintics and drug resistance. Equine anthelmintics and the resistance of nematode parasites to anthelmintics are reviewed. Recommendations are made for effective treatment of these parasites and for procedures that can be performed to minimize the problem in the future.
Effectiveness of oxfendazole against early and later 4th-stage Strongylus vulgaris in ponies. Twenty pony foals (reared worm free), 6.5 to 10 weeks of age, were inoculated with Strongylus vulgaris and allocated to 5 groups, each with 4 foals. One week after inoculation, 1 group of 4 foals was given oxfendazole (OFZ) at a dosage rate of 10 mg/kg of body weight, another group was given 2 such treatments 48 hours apart, and a 3rd group was given a placebo. All treatments were administered by stomach tube. Three weeks later, foals were euthanatized and necropsied in a test for efficacy against early 4th-stage larvae. Oxfendazole was 80% and 94.9% effective against early 4th-stage S vulgari...
Pharmacokinetics of amikacin in pony foals after a single intramuscular injection. Six healthy pony foals, from 2 to 11 days of age, were given a single IM injection of amikacin sulfate (250 mg/ml) at a dosage rate of 7 mg/kg of body weight. Serum amikacin concentrations were measured serially over a 24-hour period. The mean peak serum concentration was 14.7 micrograms/ml at 0.5 hour. The elimination rate constant for amikacin was 0.24/hour, the elimination half-life was 3.0 hours, and the apparent volume of distribution was 0.58 L/kg.
Neostigmine methylsulfate delays gastric emptying of particulate markers in horses. Eight horses were allotted to 2 groups, each of 4 horses. All horses were given 100 plastic markers intragastrically via a nasogastric tube. One group of animals (control group) was not given medication after marker administration. The other group (test group) was given neostigmine methylsulfate (0.022 mg/kg of body weight) in the subcutaneous tissue at the time of marker administration and 30, 60, and 90 minutes later. All horses were killed 135 minutes after marker administration to locate the beads in the gastrointestinal tract. Gastric emptying of the markers was significantly delayed (P l...